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ABSTRACT: The family of Angiomotin (Amot) proteins regulate
several biological pathways associated with cellular diﬀerentiation,
proliferation, and migration. These adaptor proteins target proteins to
the apical membrane, actin ﬁbers, or the nucleus. A major function of the
Amot coiled-coil homology (ACCH) domain is to initiate protein
interactions with the cellular membrane, particularly those containing
phosphatidylinositol lipids. The work presented in this article uses
several ACCH domain lysine/arginine mutants to probe the relative
importance of individual residues for lipid binding. This identiﬁed four
lysine and three arginine residues that mediate full lipid binding. Based
on these ﬁndings, three of these residues were mutated to glutamates in
the Angiomotin 80 kDa splice form and were incorporated into human
mammary cell lines. Results show that mutating three of these residues in the context of full-length Angiomotin reduced the
residence of the protein at the apical membrane. These ﬁndings provide new insight into how the ACCH domain mediates lipid
binding to enable Amot proteins to control epithelial cell growth.
■ INTRODUCTION
The family of Angiomotin (Amot) proteins regulate several
biological pathways associated with cellular diﬀerentiation,
proliferation, and migration. The Amot adaptor protein
integrates the control of cellular morphology with its proclivity
to proliferate.1−3 This is mainly accomplished through the
diﬀerential ability of speciﬁc isoforms of Amot to orient the
traﬃcking of proteins that regulate apical cell polarity with
proteins involved in the HIPPO growth control pathway.1,4
Amot localization is determined by membrane association, an
essential and conserved feature controlled by its lipid aﬃnity
comprised of the novel Amot coiled-coil homology (ACCH)
domain.5 This domain, while sharing some features of BAR
domains, speciﬁcally predicts a coiled-coil fold of approx-
imately 240 residues. This diﬀers from classical BAR domains
in that it has the unique property of being able to selectively
bind phosphatidylinositols (PIs) and cholesterol.5 However,
the mechanism by which the ACCH domain screens for these
lipids is currently unknown.
To address this gap in knowledge, we investigated the
mechanisms used by three classic domains that target PIs. The
FYVE domain contains a positively charged pocket that has
selective aﬃnity for monophosphorylated PI based on
exclusion criteria predicated on the size of the headgroup.6,7
The plekstrin homology (PH) domain contains a basic pocket
with a loop rich in lysines, arginines, and hydrophobic amino
acids that provides a size speciﬁcity towards di- and
triphosphorylated PIs.6,8 Finally, the Phox consensus sequence
(PX) motif speciﬁcally binds monophosphorylated PI3P via a
basic binding pocket.6 Similar to these domains, the ACCH
domain is also rich in lysines and arginines. Therefore, we
hypothesized that the enrichment of these positively charged
residues in the ACCH domain is essential for targeting Amot
to PI-containing membranes.
This report details the determination of speciﬁc arginine and
lysine residues within the ACCH domain that mediate the
overall aﬃnity for PI. To that end, site-directed mutagenesis
was employed to probe the speciﬁc contributions of each lysine
and arginine residue by changing them to nonpositively
charged amino acids and evaluating the resulting ability to
associate to speciﬁc PI-containing membranes by lipid
sedimentation and native tyrosine ﬂuorescence quenching.
From those screens, eight lysines and arginine residues were
selected and characterized for changes in binding aﬃnity.
Finally, in vitro experiments conﬁrmed that three of these
residues, whose mutation in the context of Amot80 led to a
change in its cellular localization, are required for full
membrane binding.
■ RESULTS
Fluorescence Quenching. The binding aﬃnity of the
ACCH domain for speciﬁc lipid compositions was measured
by the degree of tyrosine residue ﬂuorescence quenching as a
function of the concentration of various dansylated liposomes.
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In general, increasing the amount of PI-containing lipid
resulted in a decrease in tyrosine ﬂuorescence. This indicates
that the liposomes were coming into close proximity to and
quenched the ﬂuorescence of the ACCH domain tyrosines
(Figure 1). Furthermore, the AmotL1 and AmotL2 ACCH
domains bound liposomes with a similar aﬃnity as Amot80,
with around 50% of the protein bound at 8.32 mM POPC/
POPE/PI (3/1/1) liposomes, whereas no signiﬁcant binding
for any ACCH domain was seen for POPC liposomes. Similar
to results previously reported using surface plasmon
resonance,5 a 10-fold higher aﬃnity of the ACCH domain
for liposomes containing 20 mol % cholesterol was observed.
Fluorescence quenching data also indicated a ﬁrst-order
correlation between total lipid concentration and protein
bound. Hence, all screening assays for detecting decreasing
lipid aﬃnity were carried out at a saturating concentration of
20 mM lipid.
Mutant Library Screen. Based on the hypothesis that
positively charged residues in the ACCH domain mediate
binding to PIs similar to BAR, PH, and PX, and FYVE
domains, we used the WebLogo tool to determine the charge
conservation of the residues between the ACCH domains of
Amot80, AmotL1, and AmotL2, with a particular interest in
the positively charged arginines and lysines. The resulting
alignments guided our choice of residues to query further by
site-directed mutagenesis (Figure 3). A basic charge or an
exposed amine group based on pH was conserved for all lysine
and arginine residues except Lys126, Arg153, and Lys185.
Lys126 corresponds to an alanine and aspartate in AmotL1
and AmotL2, respectively. A BLAST search among all known
and predicted AmotL1 across species shows that this alanine is
completely conserved, as is the aspartate in AmotL2. We
therefore mutated this residue to a glutamate to give Amot a
similar charge−charge interaction as AmotL2.
Lys185 is conserved in AmotL2 but is a glutamate in
AmotL1. In this study, we mutated Lys185 to the same
interactions of AmotL1 while maintaining a similar space of the
other two family members.
Arg153 is conserved as an arginine in AmotL1, but using the
Weblogo alignment, we found that this residue is a highly
conserved, hydrophobic, slightly smaller leucine next to the
arginine in AmotL2. Therefore, mutating Arg153 into a
glutamate in this study reversed the charge while occupying
the same space as all of the Amot family members. A glycine
mutant was also constructed for our screening studies, which is
a much smaller, noncharged residue than either residue seen
naturally.
The lack of a signiﬁcant diﬀerence in the AC50 values
between family members suggests that a similar membrane
association would be observed when Lys126 and Lys185, and
not Arg153, were mutated to encode a negatively charged
residue.
Charge conservation was further observed for lysine residues
at positions 49, 52, 55, 62, 72, 82, 85, 87, 94, 103, 105, 111,
142, 144, 166, 179, 193, 196, 210, 217, 219, and 234. Such
conservation suggests that these residues participate in
membrane association. Site-directed mutagenesis was carried
out at the majority of these residues to encode a glutamate to
reverse the charge while retaining a similar occupying space as
the original acidic residue. Additional mutations that encode a
serine or threonine result in an exposed negatively charged
nucleophile at the original positively charged amine group.
When neither of these mutation classes proved possible, the
residue was mutated to a glycine. All of these mutations are
described in Figure 3. Based on our hypothesis, we expected to
see the most signiﬁcant reduction in membrane association for
mutations where the residue charge was the most conserved.
To screen mutants for decreased lipid binding, we ﬁrst used
the ﬂuorescence quenching assay. In this assay, each mutant
was screened for tyrosine ﬂuorescence before and after lipid
binding at a singular lipid concentration and compared to the
results obtained with the wild-type protein. Relative
ﬂuorescence after lipid association was calculated using eq 1,
and the percent change in ﬂuorescence with respect to the
wild-type protein was calculated for each mutation (Figure 3).
Of the residues tested, Arg52, Lys82, Arg85, Lys87, Arg105,
Figure 1. Quenching of Amot80 ACCH domain tyrosines by POPC (solid triangle), 3/1/1 molar ratio POPC/POPE/PI (black circle), and 2/1/
1/1 molar ratio POPC/POPE/PI/Chol (box ) liposomes that included 5 mol % dansyl DHPE. Additionally, measurements from AmotL1 (red
box) and AmotL2 (blue diamond) ACCH domain tyrosine quenched by dansylated POPC/POPE/PI are provided. Error bars are the standard
deviation of n = 3 measurements. The ﬁts of these measurements are also reported as AC50, with the respective standard error and R2 values for the
ﬁt.
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Arg153, Arg166, Lys179, Lys187, Lys193, Arg219, and Arg234
resulted in greater than 40% reduction in lipid binding.
Diﬀerences in lipid binding for each mutant was validated by
measuring their sedimentation with liposomes (Figure 2).
While sedimentation assays are generally more of a qualitative
tool for measuring relative aﬃnity, the advantage of this assay
is its independence from the requirement that the protein be in
close proximity to the dansylated lipid headgroup that could be
sequestered to PI-driven phase separations, which is then later
reorganized by the ACCH domain.9 Therefore, we did an
initial screen of the change in the ratio of protein bound/
unbound relative to the wild-type protein and reported it as
percent change (Figure 3). In these experiments, mutations at
residues Arg24, Lys49, Arg52, Lys82, Arg85, Lys87, Arg103,
Arg153, Arg166, Lys179, Lys193, Lys210, and Arg219 resulted
in a 40% or greater reduction in lipid binding relative to the
wild-type protein.
While mutations in nonconserved residues including Arg24,
Lys116, Lys126, Lys134, Lys136, Lys185, and Arg224 have
little to no eﬀect on lipid binding, the Arg153 mutant had a
signiﬁcant decrease in association to membranes, whereas
mutations in eight conserved positively charged residues
resulted in a signiﬁcant loss of membrane binding.
In summary, mutations in nine residues (Arg52, Lys82,
Arg85, Lys87, Arg153, Arg166, Lys179, Lys193, and Arg219)
resulted in at least a two-fold decrease in binding by both
screens (Figure 3). All of these mutants also showed reduced
binding by triplicate measurements of ﬂuorescence quenching
(Figure 4). Each of these mutations were further characterized
by their eﬀect on nonrelated functions, such as ability to
oligomerize, and the lipid binding AC50.
Mutation Eﬀect on Native Protein Function. The
ACCH domains of Amot family members also oligomerize, a
key function that is implicated in their roles in cells.10−13 This
study was designed to exclude mutations that had signiﬁcant
aﬀects beyond membrane association, such as a loss of globular
structural features. Each mutant was therefore also charac-
terized for diﬀerences in oligomerization using size exclusion
chromatography. Only the Arg85 mutant showed a loss of
higher-order molecular weights (Figure 5). All other mutants
therefore appear to form homo-oligomers in a similar fashion
as the wild-type domain. As a result, R85T was excluded from
further analysis.
Characterization of Mutant-Lipid Binding Aﬃnity.
The ﬂuorescence quenching assay was employed to measure
the lipid binding AC50 for each of the resulting mutants to
identify residues that participate in lipid binding (Table 2).
Mutation of a residue that participates in lipid binding should
lead to an increase in the AC50 for the ﬂuorescence quenching.
Here, we found that mutating Lys82 and Arg219 did not have
a signiﬁcant eﬀect on lipid binding. Mutating Arg153 and
Figure 2. Representative sedimentation gels for Amot and various
mutants incubated with POPC/POPE/PI (3/1/1 mole fraction). The
left lane was from the supernatant (S), and the right lane was
collected from the lipid pellet fraction (P).
Figure 3. Changes in ACCH domain liposome binding based on residue mutations. A WebLogo (http://weblogo.berkeley.edu) representation of
the negatively charged residues in the Amot80/130 ACCH domain studied in our library shows the residue and charge conservation with the
AmotL1 and AmotL2 ACCH domain sequences. Lipid binding to each mutant was initially screened by the sedimentation and ﬂuorescence
quenching assay where mutations are shaded based on changes in binding: ≥40% increase (red box), ≥20% increase (pink box), ≥20% reduction
(gray box), and ≥40% reduction (black box).
Figure 4. Veriﬁcation of mutations from an initial screen. Mutations
that initially showed at least a 40% reduction in association (Figure 3)
were veriﬁed in triplicate using the ﬂuorescence quenching assay. All
mutations led to approximately a 2-fold reduction in membrane-
associated protein.
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Lys193 led to only moderate increases in AC50 values. In
contrast, mutating Arg52, Lys87, and Lys179 caused at least a
two-fold increase in the AC50 value.
The protein lipid overlay (PLO) assay was then employed to
further study the eﬀect of these mutations on the lipid binding
aﬃnity (Table 3). Unlike the ﬂuorescence quenching assay
that utilizes multilayer lamellar vesicles with ﬂuorescently
labeled lipid headgroups incorporated throughout the entire
mixture, the PLO assay requires the lipid to be adsorbed on the
surface of a nitrocellulose membrane providing a single layer
for protein interaction. As the nitrocellulose is a stationary
phase for presentation of the lipid, the protein is only able to
associate with the presented lipid and cannot perform the lipid
phase reorganization or membrane fusion activities of the
domain that is seen in the other experimental assays used in
this study. Furthermore, we utilized the POPC/POPE/PI/
Chol (2/1/1/1 molar ratio) lipid mixture that was previously
reported to have a four-fold higher aﬃnity for the ACCH
domain using surface plasmon resonance versus the POPC/
POPE/PI (3/1/1 molar ratio) liposomes used in the
ﬂuorescence quenching assay.5 Both of these eﬀects led to an
∼1000× lower reported AC50 value for the PLO assay than
previously described (Figure 1A and Tables 1 and 3). Figure 6
shows a representative blot from this experiment. In this assay,
we found that mutating Lys87 and Arg219 had no signiﬁcant
eﬀect on their binding aﬃnity for POPC/POPE/soy PI/Chol
(2/1/1/1 molar ratio)-containing liposomes. This conﬁrms
results seen in the ﬂuorescence quenching experiment.
However, mutating Arg52, Lys82, Arg153, Lys179, and
Lys193 led to drastic decreases in association with the lipid
spots. The diﬀerence in fold change between this assay and the
ﬂuorescence quenching assay suggests that these mutations do
not have an eﬀect on the protein reorganization or fusiginic
activity that is an inherent characteristic of the domain5 but the
mutation only decreases the protein association activity. The
combination of the kinetic analyses indicated that Arg52,
Arg153, Lys179, and Lys193 might play a signiﬁcant role in the
mechanism that mediates Amot association with membranes.
Amot80 Cellular Localization. To further conﬁrm the
role of these residues on membrane aﬃnity, the residues were
then mutated in full-length Amot80 for the determination of
their eﬀect on cellular localization. As previously reported,
wild-type Amot80 localizes at the plasma membrane and at
cell-to-cell contacts.1,3,5 In contrast, deletion of the ACCH
domain ablated membrane aﬃnity, as evidenced by a complete
redistribution of protein to the cytosol.5 Variants of Amot80
were constructed with the Arg153Glu, Lys179Glu, or
Lys193Glu mutation based on our hypothesis that conversion
of positively charged residues into negatively charged ones will
Figure 5. Oligomeric states of the ACCH domain in solution. Size
exclusion chromatography elution proﬁle of puriﬁed wild type (red
line) showing three peaks corresponding to a monomer of ∼36 kDa
(∼21 mL), a tetramer of ∼135 kDa (∼16 mL), and a large aggregate
(∼8 mL). The chromatograph of the R85T mutant (blue line) shows
a peak that corresponds to the monomer and unappreciable amounts
of oligomers.
Table 1. Summary of Lipid-Related AC50 for Wild-Type
Protein (n = 3)a
lipid composition AC50 (mM) std error
POPC NB NB
POPC/POPE/soy PI(3/1/1) 11.5 0.001
POPC/POPE/soy PI/Chol(2/1/1/1) 0.014 0.001
aNB = no binding activity.
Table 2. Lipid Binding Aﬃnities for POPC/POPE/soy PI
(3/1/1) Vesicles Determined by Fluorescence Quenching
(n = 3)
mutation AC50 (mM) std error fold change
R52G 125 0.004 4
K82E 28.2 0.001 1
K87E 63.1 0.003 2
R153G 39.8 0.003 1
R166G 48.4 0.002 2
K179E 63.1 0.003 2
K193E 50.1 0.003 2
R219E 25.1 0.002 1
Table 3. Lipid Binding Aﬃnities for POPC/POPE/soy PI/
Chol (2/1/1/1) Vesicles Determined by PLO (n = 3)
mutation AC50 (μM) std error fold change
Y11,47,67,118F 16 2
R52G 288 2 18
K82E 471 2 30
K87E 55 14 3
R153G 289 2 18
R166G 25 2 2
K179E 212 7 13
K193E 171 2 11
R219E 21 3 1
Figure 6. The relative level of protein bound to lipid spots in the PLO
assay. The relative level of binding to POPC/POPE/PI/Chol (2/1/
1/1 molar ratio) lipid spots adsorbed on to nitrocellulose membranes
as a function of lipid concentration as measured by the protein lipid
overlay (PLO) assay using ﬂuorescence intensity analysis in LiCOR
Odyssey v1.2.
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prevent association with negatively charged PI membranes.
Mutants were subcloned into a YFP lentiviral construct for
stable expression in MCF7 cells (Figure 7). The percentage of
cells in which YFP-tagged protein concentrated at cell contacts
and puncta was then compared to those having a cytosolic
distribution (Figure 8).
Imaging of the R153E, K179E, and K193E mutants revealed
an increased distribution to the cytosol versus wild-type
Amot80. Because these eﬀects were not as complete as the
eﬀects previously observed upon deletion of the ACCH
domain, these mutants may still bind to previously described
membrane proteins in its signaling pathway. One limitation of
this approach is that many of the cells expressing the mutated
protein had an increased amount of protein expressing at
cytosolic puncta. Therefore, we fractionated the cells to better
determine the amount of YFP-tagged Amot protein associated
with all membranous bodies (Figure 9). In comparison to the
wild-type protein, Amot80 containing a mutation at Arg153,
Lys179, and Lys193 led to a decrease in the Amot80
localization in membranous fractions and increased localization
in cytosolic fractions. t-tests suggest that there is no signiﬁcant
diﬀerence between the amount of mutated Amot associated
with the membranes and the cytosol. However, there is a
signiﬁcant diﬀerence in the ratio of membranous/cytosolic
protein associations between the wild-type and mutant
proteins (p < 0.05). Furthermore, there is no statistically
signiﬁcant diﬀerence between the relative associations of the
mutant protein versus the expression of the empty vector (p >
0.5). These results suggested that Arg153, Lys179, and Lys193
all play a role in Amot association with membranes.
■ DISCUSSION
This study was designed to systematically determine the
relative contribution of conserved positively charged residues
within the ACCH domain that mediate lipid binding by
Angiomotin. To this end, each lysine and arginines in the
ACCH domain was mutated into either an acidic or a neutral
natural amino acid. Each of these mutants were then subjected
to initial screens for their ability to bind lipids, characterization
of the eﬀect on native functions and kinetic lipid binding
aﬃnity, and determination of eﬀects on Amot80 intracellular
localization. Each of the mutants had similar stability and were
able to be puriﬁed in a similar manner as the wild-type protein,
suggesting that most mutations had little eﬀect on overall
protein folding. Some of the key residues screened with a
glycine mutation were also conﬁrmed using the acidic
glutamate mutation later in the study.
Two orthogonal screens were used to identify ACCH
domain mutants that had reduced lipid binding. This was done
to reduce the impact of limitations in each assay. Fluorescence
quenching has long been used to study direct interactions with
naturally ﬂuorescent amino acids.14−16 In this work, the
quencher is homogeneously mixed throughout the MLV.
Decreased quenching could then be a result of decreased
membrane association and/or decreased membrane deforma-
tion/re-organization. We have recently reported that PE and PI
lipids in this mixture phase-separated from PC lipids, including
those containing ﬂuorophores, until the ACCH domain
reorganizes them into homogeneous membranes.9 This
would suggest that our ﬂuorescence quenching assay may
also show signiﬁcant changes in ﬂuorescence quenching based
on the mutant’s ability to reorganize phase separations in the
membrane. Therefore, we also incorporated the lipid
sedimentation assay as a screen, an assay frequently used to
determine the protein’s ability to associate with lipids.5,17,18
This assay would target changes in membrane association
without discriminating for membrane reorganization. The
requirement of having changes in membrane association from
both assays serves to assure that the mutations selected
retained their native membrane joining activity,5 a key function
in regulating itself and associated proteins to vesicles that are
recycled to the apical plasma membrane, regulating apical/
basal polarity and the sequestration of transcription cofactors
Figure 7. Live confocal images of ﬂuorescence in MCF7 cells stably
expressing YFP constructs (empty vector, full-length Amot80 wild
type, R153E, K179E, and K193E). Scale bars represent 10 μm.
Figure 8. Quantiﬁcation of the percent of cells with YFP-tagged
protein mainly localizing to cell contacts and puncta (black bar)
versus intracellular (white bar) expression in relation to the
localization of the empty vector and full-length Amot80 (wild type
and mutants). Results shown are in biological triplicate, and error bars
represent the standard deviation of each sample, p values against the
wild-type expression: *** < 0.0005; ** < 0.005 * < 0.05.
Figure 9. Cellular fractionation of MCF7 cells stably expressing YFP
constructs. The relative ratio of membranous (black bar) and
cytosolic (white bar) protein as determined by YFP tag ﬂuorescence
for the empty vector and full-length Amot80 (wild type and mutants).
This assay is unable to resolve intracellular membrane proteins from
other lipid environments within the cell. Results shown are in
biological triplicate, and error bars represent the standard deviation of
each sample. * denotes p < 0.005.
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responsible for controlling cellular growth, and migration and
proliferation away from the nucleus.3,10,19,20
Mutants were also tested for their ability to oligerimerize.
Studies have shown Amot heterodimerizes itself, with
Amot130 and with AmotL1.10 Furthermore, the Amot80
dimerization with Amot130 causes it to localize away from
actin and into cytosolic vesicles in a similar pattern as an
Amot80 homodimer.10 The amino acid sequence suggests that
this domain contains coiled coils, which may mediate this
ability to form dimers. Therefore, we chose to eliminate those
mutations that lost the ability to form dimers as we have
hypothesized that this function is critical to the ability to
deform and fuse membranes.21 The literature is also unclear as
to whether the ability to form dimers is critical for membrane
association. Hence, our screening assays would not be able to
account for the loss of this dimer formation as the driving force
for the decreased membrane aﬃnity for membrane or the loss
of cellular protein enrichment and localization. As a result, we
utilized size exclusion chromatography to eliminate the Arg85
mutations from further study as it only formed monomers.
The lipid binding aﬃnity for the remaining eight mutants
was then characterized. Unlike the ﬂuorescence quenching
assays, in the PLO assay, the lipid is completely adsorbed to
the surface of the nitrocellulose, thereby allowing for more
contact with all of the lipids. The combination of the two
studies allowed us to accurately determine which mutations
had the greatest eﬀect on lipid binding. The ﬂuorescence
quenching assay showed the largest decrease in the lipid
binding aﬃnity for Arg52, Lys87, and Lys179, while the PLO
assay showed similar trends. Mutating Lys87 led to a more
signiﬁcant change in binding for the rest of these mutations
except Arg219. The diﬀerences in the binding aﬃnities
reported can be accounted for by the diﬀerence in the
presentation of the lipid concentration, as the PLO data was
more similar in scale to those previously reported using surface
plasmon resonance.5
The relative eﬀect of mutating these residues was then
considered within the context of the predicted secondary
structure of the domain (Figure 10) and our previously
predicted structure of this domain.21 The ACCH domain was
predicted to be comprised of a coiled coil,5 where Arg52 and
Lys87 are in the middle of the ﬁrst α helix and Arg153, Lys179,
and Lys193 are in the middle of the second α helix (Figure
10). Lys179 and Lys193 may be along the surface of an α helix.
However, it was not clear how close in proximity this coil
would be in reference to the aforementioned residues, Arg52
or Lys87, or how this secondary coil assists the binding pocket
in binding lipids. In addition, all of these residue charges are
conserved across all of the Amot family members, further
suggesting that they may be important for lipid binding.
Several failed attempts have been made to resolve the
atomistic structure of this domain; however, we were able to
combine small-angle X-ray scattering and a homology model
building technique to create a theoretical model that could be
tested by the current results.21 Our theoretical model suggests
that the ﬁrst α-helical region participates in forming a dimer
interface while the second helix may play a stabilizing role in
the lipid binding mechanism.21 Figure 11 contains pictorial
representations of this structure while highlighting particular
regions of interest based on the current research ﬁndings in the
proposed dimer and membrane interfaces (Figure 11A,B,
respectively). Interestingly, highlighting the residues in the
second helical region that were shown in this study to mediate
association (black) versus those that did not (orange) suggests
that being positioned within a deﬁned helix decreases a
mutation’s ability to aﬀect membrane association while being
positioned within more ﬂexible regions of the domain may be
key in mediating charge-related membrane association (Figure
11C).
Arg52, Arg153, and Arg166 were identiﬁed as potential
targets in preliminary screens where the arginine had been
mutated to a glycine. The mutation had no signiﬁcant eﬀect on
puriﬁcation and stability, thereby suggesting nonsigniﬁcant
Figure 10. Predicted secondary structure of the ACCH domain using
GOR4, where 85.66% is α-helical (underlined), 1.64% is an extended
strand, and 12.7% is randomly coiled (italicized).
Figure 11. Theoretical structure of the ACCH domain. (A) Dimer
interface residues suggested to mediate membrane association. (B, C)
Membrane interface residues suggested to mediate membrane
association (black) versus the conserved arginine and lysine residues
that were not found to have a signiﬁcant role in membrane association
(orange).
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eﬀects on protein folding. However, we recognize the usage of
glycine as an alternative to the reversal of charge could have a
result in localized instability in the α-helical nature of the
coiled coil. Other reports suggest that glycine can play a key
role in homodimerization of protein α helices, are predom-
inantly oriented toward helix−helix interfaces, and have a high
occurrence at helix crossing points.22,23 Our theortical model’s
ﬁrst α-helical region is composed of four main homodimeriza-
tion interfaces.21 Arg52 was suggested to fall within the second
interface that would be stabilized by a knob-in-hole structure
(Figure 11A). Therefore, we suggest that the introduction of
this glycine mutation would probably have a little eﬀect. Our
theoretical model also suggests that residues 107−236 are
located outside of this dimer interface,21 potentially playing a
role in the protein−membrane interface, and that both Arg153
and Arg166 lie within the less rigid random coil structures on
the same interface (Figure 11B). This also suggests that
introduction of the glycine mutation probably had less of an
eﬀect on the local structure of the domain but may be able to
play key roles in membrane dynamic associations. Further-
more, we suggest that Arg153, Arg166, Lrys179, and Arg219 all
lie along the same membrane association interface while
Lys193 may lie along the opposite interface, thereby providing
a potential rationale for having ﬂexible regions of the domain.
Additionally, other studies have suggested that arginine and
lysine residues are not equivalent in their charge, leading to
potential critical diﬀerences in membrane interactions. Joseph
et al. suggests that arginine’s guanidinium group could form up
to six hydrogen bonds while lysine formed much fewer and
more ﬂexible salt bridges.24 In this protein, we studied seven
conserved arginine and four conserved lysine residues in the
predicted membrane interface region, resulting in the
identiﬁcation of Arg219 as the only conserved arginine that
mediates membrane interactions. The current study used
nonphosphorylated PI, which reduced the amount of potential
salt bridges that could potentially chemically stabilize the
protein−lipid association. Further studies with various levels of
PI phosphorylation are needed to further reﬁne the role of
forming hydrogen-bond salt bridges as a mechanism for
arginine versus lysine mediated membrane association and
selectivity.
In polarized epithelial cells, Amot family member cellular
localization has major consequences on cellular phenotypes
and has been linked to the initiation of various cancers,
including renal cell carcinoma,25 highly invasive and metastatic
breast tumors,3,26,27 osteosarcoma,28,29 prostate cancer,30 head
and neck squamous cell carcinoma,31 hepatic carcinoma,32
ovarian cancer,33 lung cancer,34 and gastric adenocarcinomas.35
As an adaptor protein, Amot80 has been shown to play a
signiﬁcant role in redistributing protein complexes that
maintain the morphology and function of intracellular
junctions and cell adhesion complexes responsible for planar
proliferation associated with normal epithelial stratum.36
Furthermore, Amot130 cellular localization has been shown
to play a signiﬁcant role in modulating HIPPO-related growth
control by redistributing cofactors YAP and TAZ, where
membrane association inhibits pro-proliferation transcription
programs37−39 and nonmembrane association causes cell cycle
activation.40,41 Therefore, determining the eﬀect of mutating
the residues within the context of the cellular environment was
key. The full-length Amot80 cellular localization studies
suggested that mutating Lys179 and Lys193 completely
disrupted ACCH domain function. However, the cellular
fractionation results from the Arg153 mutation suggest that it
had less of an eﬀect on lipid association in full-length Amot80
than the other two mutations. As the live cell imaging suggests
a greater change in localization, we hypothesized that the
protein may still be associated with inositol or negatively
charged headgroup containing vesicles within the cell.
Therefore, future studies should look at the role of this
residue lipid selectivity. Based on the collection of cellular
works presented, we conﬁrmed that three residues play a
signiﬁcant role in lipid binding: Arg153, Lys179, and Lys193.
Further studies need to conﬁrm the role of Arg52 and Lys87.
Another conﬁrmation of the role of mutating Arg153 comes
from patient data reported in the cBioPortal for Cancer
Genomics.42,43 That data suggests that mutating the Arg153
residue in both Amot80 and Amot130 to a histidine has been
the linked to the occurrence of a stomach cancer, gastric signet
ring cell carcinoma. This correlation suggests that the loss of
lipid binding associated with this charged amino acid is linked
to the initiation and progression of stomach adenocarcinoma
due to the loss of the regulation of the adaptive function of this
protein associated with the ability to colocalize with the plasma
membrane and other membranous organelles. Speciﬁcally, the
mutation of arginine to a histidine, a residue with a lower pKa,
would lead to the incorporation and presentation of a mostly
deprotonated residue. There have been reports in other
proteins such as epidermal growth factor receptor (EGFR) and
tumor protein 53 (p53) where the cancer causing Arg
mutation in nonprotonated histidine can cause drastic tilting
of the residue and α-helical shifts.44 We would hypothesize
that this mutation with the ACCH domain lipid binding would
not only eliminate the charge−charge interaction with the
inositols of the membrane but may also cause tilting, creating
more steric hinderances to the interactions that support
protein−lipid interactions in that region of the C terminus.
Future studies should utilize various protonation state
mutations for Arg153 as a means to study Amot family
members and their adaptive role in the signaling pathway
responsible for the initiation of oncogenic cellular phenotype.
■ CONCLUSIONS
In conclusion, this work paves the way for a detailed
understanding of the mechanisms involved in ACCH domain
lipid binding. We hypothesized that the ACCH domain had a
similar mechanism to other phosphatidylinositol binding
membranes, where basic residue patches mediate the aﬃnity.
This study used a detailed screening of the lysines and
arginines to determine their individual roles in mediating this
function and found three residues that appear to play a
signiﬁcant role in this membrane aﬃnity while having little to
no eﬀect on other native domain functions. Furthermore, we
were able to determine that these three residues (Arg153,
Lys179, and Lys193), which are predicted to lie along the same
face of the α helix providing a positively charged surface to
contact the negatively charged membrane,21 signiﬁcantly
increased cytosolic localization of full-length Amot80. Because
mutation of one of these residues is linked to the initiation of
stomach cancer, future studies may expand on the results here
to determine how mutations in this residue eﬀects, and the
resulting loss of Amot membrane association, may inﬂuence
the appearance of stomach cancerous phenotypes.
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■ EXPERIMENTAL
Materials. N-(5-Dimethylaminonaphthalene-1-sulfonyl)-
1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine (dansyl
DHPE) and SYPRO Red Protein Gel Stain was purchased
from Invitrogen Life Technologies (Grand Island, NY). 1-
Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC), 1-
palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine
(POPE), soy L-α-phosphatidylinositol (PI), and ovine wool
cholesterol (Chol) were purchased from Avanti Polar Lipids
(Alabaster, AL). Dodecyl thiomaltopyranoside was purchased
from Anatrace (Maumee, OH). All other materials were
purchased from Fisher Scientiﬁc (Pittsburgh, PA). Unless
otherwise noted, the buﬀer solution used for all experiments
contained 50 mM Tris, 600 mM HEPES, 300 mM NaCl, 0.5
mM EDTA, 1 mM DTT, 4 mM benzamidine, and 24.7 μM
dodecyl thiomaltopyranoside (elution buﬀer).
Plasmids. The ACCH domain sequence was previously
cloned into the pGEX vector.1,5,45−47 Mutations in the DNA
sequence were cloned into the vector using Pfu polymerase AD
in a site-directed mutagenesis polymerase chain reaction.
Lentiviral yellow ﬂuorescent protein (YFP) full-length Amot80
constructs from a previous report were used to clone in DNA
fragments containing speciﬁc mutations (Genewiz) for
expression as full-length protein.3
Protein Puriﬁcation. The Amot ACCH domain cDNA
was subcloned into the pGEX expression plasmid and
transformed into Escherichia coli BL21 (DE3) cells.48 Cells
were grown in 2× TY medium with 100 mg/L ampicillin at 37
°C. Isopropyl-β-D-thiogalactopyranoside (0.1 mM) was used to
induce protein synthesis at 16 °C overnight. Cells were
pelleted by centrifugation, solubilized in lysis buﬀer (phos-
phate-buﬀered saline solution containing 1 mM DTT, 4 mM
benzamidine, and 24.7 μM dodecyl thiomaltopyranoside), and
lysed using 50 g/L lysozyme,49 and the lysate was then
collected by centrifugation.50−52 Proteins were puriﬁed using
batch puriﬁcation of glutathione resin53−55 and eluted with an
additional 50 mM glutathione. The proteins were analyzed for
purity using SDS−PAGE and concentrated using a 10 kDa
ﬁlter tube to ≥32 μM.
Liposome Preparation. Following previously described
methods, MLV liposomes were prepared by hydrating 10−60
mg of lyophilized lipid powder in 1−6 mL buﬀer solution to
make a ﬁnal lipid concentration of 10 mM.56,57 To ensure
complete mixing, solutions were heated above their melting
temperatures to 90 °C for an hour, put through three freeze/
thaw cycles, and then sonicated for over an hour on an ice
bath. The lipid mixture was equilibrated for more than 3−5
days and stored at 4 °C.
Consensus Sequence Identiﬁcation. The Weblogo tool
(http://weblogo.berkeley.edu/) was used to generate the
consensus sequence of Amot80/130, AmotL1, and AmotL2
sequences.58 Furthermore, the tool was used to generate a
pictorial representation of the conservation of our library of
mutations at the lysine and arginine residues.
Fluorescence Quenching. We have modiﬁed previously
reported methods for intrinsic ﬂuorescence quenching by
substrates16,59 to determine quenching of intrinsic tyrosine
residues within the ACCH domain as there are no native
tryptophan residues. The protein (7 μM) was incubated with
liposomes containing 5 mol % dansyl DHPE (tyrosine
quencher) at the respective concentrations. Mutation screens
were performed against 20 mM lipid (POPC/POPE/PI, 3/1/1
mol fraction). Assays were run using a 384-well black plate
(Nunc #264556) and measured using the Molecular Devices
Flexstation II 384, where the data was collected using SoftMax
Pro v5.3. Biological triplicate measurements were taken based
on the tyrosine ﬂuorescence (274 nm excitation/303 nm
emission). Changes in tyrosine ﬂuorescence (F) due to each
lipid concentration (i) are reported as %Fluorescence using the
following equation
F F%Fluorescence / 100%i 0= * (1)
The ﬂuorescence quenching data for a series of lipid
concentrations were then ﬁt to the four-parameter sigmoidal
equation using SigmaPlot (version 10.0, StatSys) to determine
the AC50, the point where 50% of the tyrosine emission was
quenched. All data represent the average of three independent
experiments.
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The AC50 was used as a relative measurement for when half
of the protein has bound to the liposomes, a general measure
of lipid aﬃnity changes. In the mutation analysis, all of the
tyrosines, except for Tyr118, were mutated into phenylalanine,
allowing one tyrosine to be the ﬂuorescent probe to test for
quenching as function of the POPC/POPE/soy PI (3/1/1
molar ratio) multilamellar vesicle concentration.
Sedimentation Assay. We modiﬁed the lipid sedimenta-
tion assay previously described by Heller et al.5 to study 20 μM
ACCH domain protein aﬃnity for 15 mM lipid with the
following modiﬁcations. Twenty microliters of ethanol was
added to both the lipid pellet and the liquid supernatant
sample to solubilize the lipid prior to running a 12% SDS−
PAGE gel. Gels were stained using Coomassie blue stain and
analyzed using ImageJ version 1.47t. The area and mean were
used to calculate the integrated density of each band. Fractions
of lipid-bound versus unbound protein were calculated for
each mutant and compared against the fraction for the wild
type (protein with no mutation) to determine decreases in
lipid binding. The percent change in binding between the
native protein and the mutant protein of this ratio was then
reported.
Characterization of Protein Oligomer State. Puriﬁed
GST-tagged ACCH domain proteins had their GST tag
removed using a previously described methodology using
thrombin.5 Thrombin was removed using 50 kDa centrifugal
ﬁlters (Millipore). Supernatants were then loaded onto a
glutathione resin column, and eluants containing the cleaved
protein were collected and concentrated. The puriﬁed protein
was then loaded onto a Superdex 75 Prep Grade resin (GE
Healthcare) column previously equilibrated with the elution
buﬀer and calibrated with low- and high-molecular-weight gel
ﬁltration calibration kits (Millipore).
Protein Lipid Overlay (PLO) Assay. The protein lipid
overlay (PLO) assay was performed as previously described,60
with the following procedural modiﬁcations. Previously
described liposomes were diluted, incubated for 1 h, and
then blotted onto the nitrocellulose membrane (Ambersham
Hybond ECL Membrane, GE Healthcare). The membrane was
then blocked at room temperature for 30 min in PBS buﬀer
containing 0.1% Triton-X and 1% (w/v) nonfat dry milk. The
membrane was then incubated for an additional 30 min in 2
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μM puriﬁed protein, washed in PBST, and incubated with the
anti-GST antibody DyLight 680 conjugate (1/1000 dilution)
(MA4-004-D680, Thermo Scientiﬁc). The membrane was
rinsed in PBST, and the bound protein was then analyzed
using a LiCOR Biosciences imaging station where the
ﬂuorescence intensity was analyzed using Odyssey v1.2 as
previously reported.3
Mammalian Cell Culture. Human embryonic kidney
(HEK) 293 T cells and MCF7 cells (C. Wells, Indiana
University School of Medicine) were cultured in DMEM with
10% FBS at 37 °C in 5% CO2 (v/v). Transfections and
lentiviral production were carried out in HEK293T cells, and
stable viral infection were carried out in MCF7 cells as
previously described.3,20 Live cell ﬂuorescence images were
acquired, and the images were processed and analyzed using
Zeiss Axiovision (v. 4.8) using a methodology previously
described.5,20 Cells were also separated into their nuclear,
cytosolic, and membranous components (BioVision K270-50)
as previously described.61−65 Aliquots of each fraction (2 μg)
were then analyzed for their YFP ﬂuorescence to determine the
relative percentage of the YFP-tagged Amot80 found in each
fraction.
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